The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states

dc.contributor.authorRasche, Leo
dc.contributor.authorSchinke, Carolina
dc.contributor.authorMaura , Francesco
dc.contributor.authorBauer , Michael A.
dc.contributor.authorAshby, Cody
dc.contributor.authorDeshpande , Shayu
dc.contributor.authorPoos , Alexandra M.
dc.contributor.authorZangari , Maurizio
dc.contributor.authorThanendrarajan, Sharmilan
dc.contributor.authorDavies, Faith E.
dc.contributor.authorWalker, Brian A.
dc.contributor.authorBarlogie, Bart
dc.contributor.authorLandgren, Ola
dc.contributor.authorMorgan, Gareth J.
dc.contributor.authorvan Rhee, Frits
dc.contributor.authorWeinhold , Niels
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2024-05-14T19:27:19Z
dc.date.available2024-05-14T19:27:19Z
dc.date.issued2022-08-03
dc.description.abstractDeciphering Multiple Myeloma evolution in the whole bone marrow is key to inform curative strategies. Here, we perform spatial-longitudinal whole-exome sequencing, including 140 samples collected from 24 Multiple Myeloma patients during up to 14 years. Applying imaging-guided sampling we observe three evolutionary patterns, including relapse driven by a single-cell expansion, competing/co-existing sub-clones, and unique sub-clones at distinct locations. While we do not find the unique relapse sub-clone in the baseline focal lesion(s), we show a close phylogenetic relationship between baseline focal lesions and relapse disease, highlighting focal lesions as hotspots of tumor evolution. In patients with ≥3 focal lesions on positron-emission-tomography at diagnosis, relapse is driven by multiple distinct sub-clones, whereas in other patients, a single-cell expansion is typically seen (p < 0.01). Notably, we observe resistant sub-clones that can be hidden over years, suggesting that a prerequisite for curative therapies would be to overcome not only tumor heterogeneity but also dormancy.
dc.eprint.versionFinal published version
dc.identifier.citationRasche, L., Schinke, C., Maura, F., Bauer, M. A., Ashby, C., Deshpande, S., Poos, A. M., Zangari, M., Thanendrarajan, S., Davies, F. E., Walker, B. A., Barlogie, B., Landgren, O., Morgan, G. J., van Rhee, F., & Weinhold, N. (2022). The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states. Nature Communications, 13(1), 4517. https://doi.org/10.1038/s41467-022-32145-y
dc.identifier.urihttps://hdl.handle.net/1805/40743
dc.language.isoen_US
dc.publisherSpringer
dc.relation.isversionof10.1038/s41467-022-32145-y
dc.relation.journalNature Communications
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourcePublisher
dc.subjectCancer genomics
dc.subjectCancer imaging
dc.subjectMyeloma
dc.subjectTumour heterogeneity
dc.titleThe spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Rasche2022Spatio-CCBY.pdf
Size:
3.19 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: